[go: up one dir, main page]

WO2002019998A3 - Traitement des prises de poids associees a l'utilisation d'antipsychotiques atypiques - Google Patents

Traitement des prises de poids associees a l'utilisation d'antipsychotiques atypiques Download PDF

Info

Publication number
WO2002019998A3
WO2002019998A3 PCT/US2001/022621 US0122621W WO0219998A3 WO 2002019998 A3 WO2002019998 A3 WO 2002019998A3 US 0122621 W US0122621 W US 0122621W WO 0219998 A3 WO0219998 A3 WO 0219998A3
Authority
WO
WIPO (PCT)
Prior art keywords
weight gain
atypical antipsychotic
gain associated
treating weight
antipsychotic use
Prior art date
Application number
PCT/US2001/022621
Other languages
English (en)
Other versions
WO2002019998A2 (fr
Inventor
Alan Breier
Mark Louis Heiman
John David Leander
Original Assignee
Lilly Co Eli
Alan Breier
Mark Louis Heiman
John David Leander
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Alan Breier, Mark Louis Heiman, John David Leander filed Critical Lilly Co Eli
Priority to AU2001282913A priority Critical patent/AU2001282913A1/en
Publication of WO2002019998A2 publication Critical patent/WO2002019998A2/fr
Publication of WO2002019998A3 publication Critical patent/WO2002019998A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une méthode permettant de traiter les gains pondéraux associés à l'utilisation d'antipsychotiques atypiques. Cette méthode consiste à administrer à un mammifère nécessitant un tel traitement une dose thérapeutiquement efficace de chlorhydrate de N,N-diméthyl-1-[1-(4-chlorophényl) cyclobutyl]-3-méthylbutylamine.
PCT/US2001/022621 2000-09-08 2001-08-24 Traitement des prises de poids associees a l'utilisation d'antipsychotiques atypiques WO2002019998A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001282913A AU2001282913A1 (en) 2000-09-08 2001-08-24 A method of treating weight gain associated with atypical antipsychotic use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23106500P 2000-09-08 2000-09-08
US60/231,065 2000-09-08

Publications (2)

Publication Number Publication Date
WO2002019998A2 WO2002019998A2 (fr) 2002-03-14
WO2002019998A3 true WO2002019998A3 (fr) 2003-01-23

Family

ID=22867618

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/022621 WO2002019998A2 (fr) 2000-09-08 2001-08-24 Traitement des prises de poids associees a l'utilisation d'antipsychotiques atypiques

Country Status (2)

Country Link
AU (1) AU2001282913A1 (fr)
WO (1) WO2002019998A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE486842T1 (de) 2002-03-12 2010-11-15 Merck Sharp & Dohme Substituierte amide
DE60330864D1 (de) 2002-06-19 2010-02-25 Biovitrum Ab Publ Neue verbindungen, deren verwendung und herstellung
CA2622696A1 (fr) * 2007-11-05 2009-05-05 Diane Mcintosh Methodes et compositions pour retarder le gain de poids associe a l'utilisation de medicaments antipsychotiques atypiques
WO2014078568A1 (fr) 2012-11-14 2014-05-22 The Johns Hopkins University Méthodes et compositions pour le traitement de la schizophrénie

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436272A (en) * 1988-11-29 1995-07-25 The Boots Company (Usa), Inc. Treatment of obesity
US5736541A (en) * 1995-03-24 1998-04-07 Eli Lilly And Company Olanzapine polymorph crystal form
WO2000056313A1 (fr) * 1999-03-19 2000-09-28 Knoll Gmbh Procede de lutte contre le gain de poids associe a des medicaments therapeutiques

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436272A (en) * 1988-11-29 1995-07-25 The Boots Company (Usa), Inc. Treatment of obesity
US5736541A (en) * 1995-03-24 1998-04-07 Eli Lilly And Company Olanzapine polymorph crystal form
WO2000056313A1 (fr) * 1999-03-19 2000-09-28 Knoll Gmbh Procede de lutte contre le gain de poids associe a des medicaments therapeutiques

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ALLISON D.B. ET AL: "Antipsychotic -induced weight gain: A review of the literature.", JOURNAL OF CLINICAL PSYCHIATRY, (2001) 62/SUPPL. 7 (22-31)., XP008005159 *
BLACKBURN G.L. ET AL: "Weight gain and antipsychotic medication.", JOURNAL OF CLINICAL PSYCHIATRY, (2000) 61/SUPPL. 8 (36-42)., XP008005169 *
CASEY D.E. ET AL: "The pharmacology of weight gain with antipsychotics.", JOURNAL OF CLINICAL PSYCHIATRY, (2001) 62/SUPPL. 7 (4-10)., XP008005168 *
GREENBERG ISAAC ET AL: "Nonpharmacologic and pharmacologic management of weight gain.", JOURNAL OF CLINICAL PSYCHIATRY, vol. 60, no. SUPPL. 21, 1999, pages 31 - 36, XP008005348, ISSN: 0160-6689 *
KURZTHALER I. ET AL: "The clinical implications of weight gain in schizophrenia.", JOURNAL OF CLINICAL PSYCHIATRY, (2001) 62/SUPPL. 7 (32-37)., XP008005160 *

Also Published As

Publication number Publication date
WO2002019998A2 (fr) 2002-03-14
AU2001282913A1 (en) 2002-03-22

Similar Documents

Publication Publication Date Title
NO2010006I2 (no) Saksagliptin og farmasøytisk akseptable salter derav, inklusive saksagliptin hydroklorid
AP2002002703A0 (en) Combinations of depeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diadetes mellitus.
DK1333887T3 (da) Kombinationsbehandling omfattende antidiabetiske og antikonvulsive midler
MXPA03003029A (es) Combinaciones de productos activos con propiedades insecticidas, fungicidas y acaricidas.
NO20025999L (no) Klart, vandig anestetisk preparat
WO2002019998A3 (fr) Traitement des prises de poids associees a l'utilisation d'antipsychotiques atypiques
WO2000056315A8 (fr) Traitement de la douleur
UA49025C2 (uk) Спосіб лікування (варіанти) та профілактики серцево-судинних захворювань
WO2002044384A3 (fr) Epitopes lymphocytaires t des proteines l1 et e7 de papillomavirus et leur utilisation a des fins de diagnostic et de therapie
HUP0200501A3 (en) Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for treating sleep apnoea
AUPQ938700A0 (en) Antifungal combination use
GB0202337D0 (en) Cancer treatment
WO2001089527A3 (fr) Compositions solides et liquides stables
Farmer The EC water framework Directive: an introduction
Liangrong Pragmatic Markers for Understanding Vague Utterances
일본인 et al. elllll (C) 2003 NuriMedia Co., Ltd.(1142)
李立菲 Words and expressions for practice
Stirk HOW TO GIVE A SHORT SPEECH
张文华 Marguerite Duras
郭葭 Who's Perfume
蒙塔古 et al. The Unquiet Grave
TW462447U (en) Improved structure for two-stage check relief valve
马立平 Sugar-fuelled Mobile Phones
巩志平 The Stylistics of Fiction: An Effective Way Towards Fiction
WO2000056316A8 (fr) Traitement des calculs biliaires

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP